Budesonide

CAS 51333-22-3 28 current recordsSmall Molecule

Who holds supplier records for Budesonide? 28 organisations hold a current record for Budesonide: an active US FDA Type II Drug Master File or a CEP. 20 of them hold a valid EU Certificate of Suitability (21 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (8), China (5), Italy (4), Netherlands (2) and 5 other countries (5); not recorded for 4.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Budesonide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/budesonide

Reading the evidence

  • 28 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 15 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Budesonide expires 23 Jan 2043. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (28)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Budesonide. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • CURIA SPAIN SAU
    Active DMF 25629, 19528 · latest filing Dec 2011
    SpainCEP Company GMP cert on record
  • Farmabios S.p.A.
    Active DMF 15298, 25615, 13013 +1 · latest filing Dec 2011
    ItalyCEP Company GMP cert on record
  • TAPI NL BV
    Active DMF 16932, 10976 · latest filing Oct 2003
    NetherlandsCEP
  • BREATHGREEN PHARMACEUTICAL CO LTD
    Active DMF 38373, 39691 · latest filing Mar 2024
  • AARTI PHARMALABS LIMITED
    Active DMF 20609 · latest filing Jun 2007
    IndiaCEP
  • ASPEN OSS BV
    Active DMF 10493 · latest filing Sept 1993
    NetherlandsCEP Company GMP cert on record
  • Aurisco Pharmaceutical Co.,ltd
    Active DMF 41233 · latest filing Jan 2025
    ChinaCEP Company GMP cert on record
  • Cipla Limited
    Active DMF 27461 · latest filing Mar 2014
    IndiaCEP Company GMP cert on record
  • CORAL DRUGS PVT LTD
    Active DMF 30534 · latest filing Feb 2017
    IndiaCEP Company GMP cert on record
  • HENAN LIHUA PHARMACEUTICAL CO LTD
    Active DMF 35859 · latest filing Sept 2021
    CEP
  • Hubei Gedian Humanwell Pharmaceutical Co. Ltd
    Active DMF 34268 · latest filing Oct 2019
    ChinaCEP Company GMP cert on record
  • INDUSTRIALE CHIMICA SRL
    Active DMF 15877, 20010 · latest filing Nov 2006
    ItalyCEP Company GMP cert on record
  • MINAKEM
    Active DMF 28441 · latest filing Jun 2014
    FranceCEP
  • NEWCHEM SPA
    Active DMF 25319 · latest filing Aug 2011
    ItalyCEP Company GMP cert on record
  • STERLING SPA
    Active DMF 22641 · latest filing Mar 2009
    ItalyCEP Company GMP cert on record
  • Sun Pharmaceutical Industries Limited
    Active DMF 26445 · latest filing Sept 2013
    IndiaCEP Company GMP cert on record
  • TIANJIN TIANYAO PHARMACEUTICALS CO LTD
    Active DMF 32195 · latest filing Oct 2017
    ChinaCEP
  • VAMSI LABS LTD
    Active DMF 43806 · latest filing Apr 2026
    IndiaCEP Company GMP cert on record
  • Amphastar Nanjing Pharmaceuticals
    Active DMF 33714 · latest filing Aug 2019
    China
  • Apotex Inc.
    Active DMF 27451 · latest filing Nov 2013
    Canada
  • AstraZeneca Pharmaceuticals LP
    Active DMF 33171 · latest filing Oct 2018
    USA Company GMP cert on record
  • CHEMO IBERICA SA
    Active DMF 39504 · latest filing Apr 2024
  • SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD
    Active DMF 44209 · latest filing May 2026
  • SYMBIOTEC PHARMALAB PRIVATE LTD
    Active DMF 44046 · latest filing Apr 2026
    India Company GMP cert on record
  • XUZHOU WANBANG JINQIAO PHARMA CO LTD
    Active DMF 44469 · latest filing Sept 2026
    China
  • FinlandCEP Company GMP cert on record
  • SHAKTI LIFESCIENCE PRIVATE LIMITED
    IndiaCEP
  • AVIK PHARMACEUTICAL LIMITED
    Valid CEP holder (EDQM); not necessarily the manufacturer
    IndiaCEP
Need Budesonide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (21)

Certificates of Suitability on the EDQM register for Budesonide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 33 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
STERLING S.p.A. CorcianoIT
CEP 2017-138 - Rev 06
Budesonide, Codes 201680 and 2016112
Sept 2026Inspected Dec 2025
Italy
AURISCO PHARMACEUTICAL CO., LTD. TiantaiCN
CEP 2025-046 - Rev 01
Budesonide, Micronised
Jul 2026Inspected Dec 2023
Germany
CURIA SPAIN S.A.U. BoecilloES
CEP 2009-037 - Rev 03
Budesonide, Sterile
Jul 2026Inspected Feb 2026
Spain
AVIK PHARMACEUTICAL LIMITED VapiIN
CEP 2014-177 - Rev 01
Budesonide
Jul 2026—
VAMSI LABS LIMITED SolapurIN
CEP 2024-441 - Rev 01
Budesonide, Micronised
Jul 2026—
CORAL DRUGS PRIVATE LIMITED New DelhiIN
CEP 2016-020 - Rev 01
Budesonide
Jan 2026—
MINAKEM DunkerqueFR
CEP 2010-190 - Rev 04
Budesonide, Micronised, non-micronised
Dec 2025—
TAPI NL B.V. AmsterdamNL
CEP 2014-051 - Rev 02
Budesonide, T Process
Jul 2025—
FERMION OY EspooFI
CEP 2025-102 - Rev 00
Budesonide, Process 2B, micronised
May 2025Inspected Feb 2026
Finland
HENAN LIHUA PHARMACEUTICAL CO., LTD. AnyangCN
CEP 2021-346 - Rev 01
Budesonide
Mar 2025—
HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou CityCN
CEP 2019-295 - Rev 02
Budesonide, Micronised
Dec 2024Inspected Nov 2023
Germany
SHAKTI LIFESCIENCE PRIVATE LIMITED MumbaiIN
CEP 2022-210 - Rev 00
Budesonide
Sept 2024—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2018-064 - Rev 01
Budesonide
Aug 2024—
CIPLA LIMITED MumbaiIN
CEP 2006-061 - Rev 03
Budesonide
Jun 2024—
NEWCHEM S.p.A. MilanoIT
R1-CEP 2009-185 - Rev 03
Budesonide, Micronised, non-micronised
Jul 2023—
ASPEN OSS B.V. OssNL
R0-CEP 2021-491 - Rev 01
Budesonide, Budesonide ZS
Feb 2023—
AARTI PHARMALABS LIMITED Mulund (W), MumbaiIN
R1-CEP 2006-295 - Rev 04
Budesonide
Oct 2022—
FARMABIOS S.p.A Gropello CairoliIT
R1-CEP 2005-174 - Rev 01
Budesonide, Micronised, grades 21, 22 and 23
Jul 2017—
STERLING S.p.A. Solomeo Di CorcianoIT
R1-CEP 2009-057 - Rev 00
Budesonide
Oct 2015—
INDUSTRIALE CHIMICA S.R.L. SaronnoIT
R1-CEP 2000-152 - Rev 04
Budesonide
Mar 2012—
TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. TianjinCN
R1-CEP 2000-038 - Rev 04
Budesonide
Dec 2011—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (35 listed products contain Budesonide). The latest listed patent expires 23 Jan 2043. The latest listed exclusivity runs to 9 Feb 2031. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Budesonide is a potent corticosteroid used primarily for its anti-inflammatory properties. It is commonly used in the treatment of asthma, inflammatory bowel diseases, and allergic rhinitis.

Chemical identity

IUPAC name
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
Canonical SMILES
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C
InChIKey
VOVIALXJUBGFJZ-KWVAZRHASA-N
Synonyms
Entocort API, airsupra component budesonide, breztri component budesonide, entocort, entocort ec, eohilia, map-0010, map0010, nsc-757788, ortikos, pulmicort, r01ad05

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Corticosteroid
Mechanism of action
Corticosteroid Hormone Receptor Agonists

Therapeutic areas

Respiratory SystemGastroenterologyAllergy and Immunology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Budesonide?

28 organisations hold an active US FDA Type II Drug Master File or a CEP for Budesonide: CURIA SPAIN SAU (Spain), Farmabios S.p.A. (Italy), TAPI NL BV (Netherlands), BREATHGREEN PHARMACEUTICAL CO LTD, AARTI PHARMALABS LIMITED (India), ASPEN OSS BV (Netherlands), Aurisco Pharmaceutical Co.,ltd (China) and Cipla Limited (India), and 20 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Budesonide Drug Master Files are active?

CURIA SPAIN SAU (DMF 25629, 19528), Farmabios S.p.A. (DMF 15298, 25615), TAPI NL BV (DMF 16932, 10976), BREATHGREEN PHARMACEUTICAL CO LTD (DMF 38373, 39691), AARTI PHARMALABS LIMITED (DMF 20609), ASPEN OSS BV (DMF 10493), Aurisco Pharmaceutical Co.,ltd (DMF 41233) and Cipla Limited (DMF 27461) and 17 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Budesonide have a European Certificate of Suitability?

Yes. 20 organisations hold a valid CEP for Budesonide on the EDQM register, including STERLING S.p.A. Corciano (IT), AURISCO PHARMACEUTICAL CO., LTD. Tiantai (CN), CURIA SPAIN S.A.U. Boecillo (ES), AVIK PHARMACEUTICAL LIMITED Vapi (IN), VAMSI LABS LIMITED Solapur (IN) and CORAL DRUGS PRIVATE LIMITED New Delhi (IN) and 15 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Budesonide?

Yes. The latest patent listed for an approved US product containing Budesonide expires 23 Jan 2043, across 35 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Budesonide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Budesonide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.